Biosignal-based screening using electrocardiograms (ECGs) has emerged as a practical approach for detecting latent cardiac dysfunction in real-world clinical settings. However, left bundle branch block (LBBB) introduces characteristic conduction-relat...
Biosignal-based screening using electrocardiograms (ECGs) has emerged as a practical approach for detecting latent cardiac dysfunction in real-world clinical settings. However, left bundle branch block (LBBB) introduces characteristic conduction-related morphological changes (e.g., widened QRS and altered repolarization patterns) that can substantially degrade the generalization performance of ECG-based left ventricular systolic dysfunction (LVSD) detection models trained on general populations. In this thesis, we propose an LBBB-specific deep learning framework for LVSD prediction using 12-lead ECGs, with an emphasis on robust performance under limited-data conditions and improved clinical interpretability.
First, we develop a residual-driven modeling pipeline that combines an autoencoder-based anomaly representation with a convolutional neural network (CNN) classifier. The autoencoder is trained to reconstruct non-LVSD ECG patterns, and the resulting reconstruction residuals are leveraged as informative cues to enhance separability between non-LVSD and LVSD in the LBBB cohort. Second, to fully exploit multi-lead information while maintaining model simplicity, we introduce a lead-wise ensemble strategy that aggregates predictions from single-lead CNN models, enabling stable decision-making without requiring a heavy multi-branch architecture. Finally, we apply Grad-CAM-based explainability to identify lead-dependent salient regions and support qualitative interpretation of model decisions.
Experimental evaluation on an LBBB-specific dataset demonstrates that the single-lead CNN baseline achieved an accuracy of 0.74 and an AUC of 0.69, whereas the proposed lead-wise ensemble improved performance to an accuracy of 0.81 and an AUC of 0.75. In addition, an external validation using a publicly available model trained on a general population showed marked performance degradation on the LBBB cohort (AUC 0.56), highlighting the necessity of LBBB-tailored modeling. A ResNet-based LBBB-oriented comparator exhibited high sensitivity but low specificity (AUC 0.86; specificity 0.40), suggesting that complex architectures may overfit or become sensitivity-biased under small-cohort constraints. Collectively, these results indicate that a residual-informed, lead-wise ensemble approach can provide a balanced and practically deployable solution for LVSD screening in the LBBB population.